MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Evaluating a Novel Home-Based Care Pathway for People with Parkinson’s Disease

E. King, J. Abraham, E. Edwards, T. Gorst, M. Holley, J. Inches, T. North, J. Rideout, S. Whipps, C. Carroll (Plymouth, United Kingdom)

Meeting: MDS Virtual Congress 2021

Abstract Number: 499

Keywords: Parkinson’s

Category: Parkinson’s Disease: Pharmacology and Therapy

Objective: To evaluate the acceptability, feasibility, safety and effectiveness of a novel remotely delivered Parkinson’s care pathway.

Background: Current care pathways for people with Parkinson’s (PwP) are not tailored to individual need.  At University Hospitals Plymouth NHS Trust, UK, we have implemented a novel Parkinson’s care pathway, co-designed with PwP, Home-Based Care (HBC). HBC provides personalised care through supported self-management, triggered contacts and digitally-enabled remote monitoring. Here we have evaluated acceptability, feasibility, safety, and effectiveness.

Method: Evaluation was performed at baseline and 6-months of motor (UPDRS II and accelerometer) and non-motor (NMSQ, PDSS2, HADS) symptoms, acceptability and self-management efficacy. Care was audited against Parkinson’s UK national audit standards. Process measures captured feasibility. Safety was assessed via triggered contacts and questionnaire completion/return rates. Carer and patient experience was evaluated by framework analysis of transcripts from semi-structured interviews. Staff wellbeing was assessed using the Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS).

Results: From Oct 2019 to January 2021, 111 PwP were enrolled onto HBC; data are available from 111 patients at baseline and 53 at 6m. Overall, over 90% of all questionnaires were returned, 97% being complete or having no more than 2 missing items. Reporting and communications occurred within the timeframes agreed with patients. Compared with baseline, after 6m on HBC, fewer PwP had severe non-motor symptom burden (33% vs 51%), depression (3% vs 9%) and anxiety (10% vs 19%); median UPDRS II improved from 12.0 to 9.0; more PwP had controlled bradykinesia (22% vs 30%); PwP felt more involved in care (59% vs 41%), listened to (63% vs 47%) and treated as an individual (71% vs 57%), as well as having increased PD understanding (47% vs 40%). HBC met 93% of national audit criteria. There was a significant improvement in staff wellbeing, with a mean improvement of 9.8% in WEMWBS score (n=8).  Key themes from the interviews included increased feelings of autonomy for PwP, and empowerment for carers, encouraging a pro-active approach to symptom management.

Conclusion: We have demonstrated acceptability, feasibility and effectiveness of our novel remotely-delivered Parkinson’s care pathway, with benefits for PwP and staff involved in their care.

To cite this abstract in AMA style:

E. King, J. Abraham, E. Edwards, T. Gorst, M. Holley, J. Inches, T. North, J. Rideout, S. Whipps, C. Carroll. Evaluating a Novel Home-Based Care Pathway for People with Parkinson’s Disease [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/evaluating-a-novel-home-based-care-pathway-for-people-with-parkinsons-disease/. Accessed May 15, 2025.
  • Tweet
  • Email
  • Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/evaluating-a-novel-home-based-care-pathway-for-people-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley